2 results
Approved WMORecruiting
The primary objective of this study is to compare PFS with LY2875358 plus erlotinib therapy with erlotinibmonotherapy as first-line treatment in metastatic NSCLC patients with activating EGFR mutations who havedisease control after an 8-week lead-in…
Approved WMOPending
The aim of this study is to compare the 3D designed prosthesis with the conventional made prosthesis.Study questions:- How is the 3D designed prosthesis compared to the conventional prosthesis? The final chosen workflow and settings will be applied…